RAYMOND C TAN

Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology FRESNO, CA NPI 1104809946

General Payments — all program years on this page

$1,484.29

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 66
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $541.01 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $541.0120

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $330.7316
2019 $23.781
2020 $32.442
2021 $16.361
2022 $228.2213
2023 $311.7513
2024 $541.0120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078298055 Janssen Biotech, Inc. $26.58 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1084898319 Hologic Sales and Service, LLC $19.78 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086121412 Bayer Healthcare Pharmaceuticals Inc. $21.35 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086201636 Bayer Healthcare Pharmaceuticals Inc. $18.73 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092725700 Boston Scientific Corporation $39.15 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104308744 AstraZeneca Pharmaceuticals LP $69.18 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105304775 AstraZeneca Pharmaceuticals LP $29.02 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105560280 AstraZeneca Pharmaceuticals LP $27.30 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105777024 AstraZeneca Pharmaceuticals LP $22.72 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105823743 AstraZeneca Pharmaceuticals LP $25.91 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105851056 AstraZeneca Pharmaceuticals LP $22.92 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110775595 Eisai Inc. $20.01 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114210710 Regeneron Healthcare Solutions, Inc. $22.84 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126831076 Genmab U.S., Inc. $24.10 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128508956 PROGENICS PHARMACEUTICALS, INC. $20.98 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131247893 PFIZER INC. $25.19 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138564396 Exelixis Inc. $23.65 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141416306 SOBI, INC $33.23 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148926290 Sumitomo Pharma America, Inc. $27.60 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152541085 Myriad Genetic Laboratories, Inc. $20.77 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.